Emory HIV/AIDS Clinical Trials Unit

埃默里艾滋病毒/艾滋病临床试验单位

• 批准号: 8197411
• 负责人: Jeffrey Lennox
• 金额: $ 195.21万
• 依托单位: EMORY UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-02-01 至 2013-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8197411
• 关键词: AIDS clinical trial group; AIDS/HIV problem; Accounting; Acquired Immunodeficiency Syndrome; Adult; African American; Agreement; Area; Caring; Cities; Clinic; Clinical Research; Clinical Trials Unit; Communicable Diseases; Country; Doctor of Medicine; Epidemic; Faculty; Female; HIV; HIV Vaccine Trials Network; HIV prevention trials network; HIV vaccine; Hispanics; Leadership; Medical center; Microbicide Trials Network; Minority; National Institute of Allergy and Infectious Disease; Population; Principal Investigator; Reporting; Research; Scientist; Site; Testing; United States; United States Department of Veterans Affairs; Universities; Vaccines; Veterans; Woman; Work; clinical research site; men; metropolitan; microbicide; patient population

DESCRIPTION (provided by applicant): Through this application, NIAID-sponsored clinical research at Emory University will be integrated into the Emory HIV/AIDS Clinical Trials Unit (EHCTU). The EHCTU will perform clinical research trials through prior agreement with the AIDS Clinical Trials Group (ACTG) and the Microbicides Trials Network (MTN). In addition, the EHCTU has the scientific expertise and appropriate patient populations to make important contributions to the HIV Vaccine Trials Network (HVTN), the HIV Prevention Trials Network (HPTM) and the INSIGHT network. Emory scientists currently make important scientific and leadership contributions to each of these networks. Emory University is located in Atlanta, a city at the epicenter of the evolving HIV epidemic in the United States. Of the 101 metropolitan areas with a population greater than 500,000, Atlanta ranked 7th for AIDS reporting in 2003. Atlanta accounts for 67% of Georgia's African-American AIDS cases, 75% of Hispanic cases, and 56% of minority female cases. Emory faculty provides care for about6,000 HIV-infected men and over 1,000 infected women. The EHCTU will consist of an administrative core and three clinical research sites. Jeffrey Lennox, M.D. will be the Principal Investigator for the EHCTU and for the ACTG at Emory. Carlos del Rio, M.D. will be the Principal Investigator for the HPTN trials. The Ponce de Leon Center, where over 4,000 HIV-infected adults are in care, will be the research site for the ACTG and HPTN. Francis Priddy, M.D. will be the Principal Investigator for the HVTN and MTN trials. These trials will be done at the Hope Clinic of the Emory Vaccine Center, one of the leading HIV vaccine and microbicides testing sites in the United States. David Rimland, M.D. will be the Principal Investigator for the INSIGHT trials. These trials will be performed at the Atlanta Veterans Administration Medical Center, which has the largest population of HIV-infected veterans in the country. Dr's Lennox, del Rio, Priddy and Rimland are all faculty in the Division of Infectious Diseases, have an excellent working relationship and a demonstrated record of collaborative clinical research accomplishments. ADMINISTRATIVE COMPONENT:

描述（由申请人提供）：通过此申请，Emory University的NIAID赞助的临床研究将集成到Emory HIV/AIDS临床试验单元（EHCTU）中。 EHCTU将通过与AIDS临床试验组（ACTG）和Microbicides试验网络（MTN）进行事先同意进行临床研究试验。此外，EHCTU具有科学专业知识和适当的患者人群，可以为HIV疫苗试验网络（HVTN），HIV预防试验网络（HPTM）和Insight网络做出重要贡献。埃默里（Emory）科学家目前对这些网络中的每个网络做出重要的科学和领导贡献。埃默里大学（Emory University）位于亚特兰大，这是美国不断发展的艾滋病毒流行病的城市。人口超过500,000的101个大都市地区，亚特兰大在2003年的艾滋病报道中排名第七。亚特兰大占乔治亚州非裔美国人艾滋病案件的67％，占西班牙裔案件的75％，占少数民族女性的56％。埃默里（Emory）教师为约6,000名受艾滋病毒感染的男性和1,000多名受感染的妇女提供护理。 EHCTU将由行政核心和三个临床研究站点组成。杰弗里·伦诺克斯（Jeffrey Lennox），医学博士将担任EHCTU的主要研究员和Emory的ACTG。医学博士Carlos del Rio将成为HPTN试验的主要研究员。 Ponce de Leon中心在那里有4000多名HIV感染的成年人，将成为ACTG和HPTN的研究地点。弗朗西斯·普里迪（Francis Priddy），医学博士将成为HVTN和MTN试验的主要研究员。这些试验将在埃默里疫苗中心的Hope诊所进行，这是美国领先的HIV疫苗和微生物测试地点之一。医学博士David Rimland将成为Insight试验的主要研究者。这些试验将在亚特兰大退伍军人管理局医疗中心进行，该医疗中心拥有该国艾滋病毒感染者最多的退伍军人。博士的Lennox，Del Rio，Priddy和Rimland都是传染病部门的教职员工，具有良好的工作关系，并有了合作临床研究成就的记录。 管理组件：